COMP <GO>
UHS vs HCA // EV/EBITDA & P/E VALUATION
Universal Health Services Inc. (NYSE) VS. HCA Healthcare Inc. (NYSE) • 15-METRIC TALLY: UHS 6
— HCA 6
▲ EV/EBITDA & P/E VALUATION LEADER: UHS
LAST: $176.05 (-0.32%) • MKT CAP: $10.41B
valuation
5.0x
LAST: $473.19 (-1.02%) • MKT CAP: $103.51B
valuation
11.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UHS VS. HCA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UHS | HCA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.10% | 18.90% | -4.80 | HCA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 5.0x | 11.5x | -6.50 | UHS | /valuation <GO> |
| Free Cash Flow Yield | 8.16% | 7.43% | +0.73 | UHS | /fcf-yield <GO> |
| Operating Margin | 11.50% | 10.90% | +0.60 | UHS | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 9.00% | -0.40 | HCA | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 7.10% | +2.60 | UHS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.49% | 0.66% | -0.17 | HCA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.11 | 3.68 | -0.57 | HCA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | UHS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.5 | 62.6 | -16.10 | HCA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 1.04 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.5x | 14.2x | -7.70 | UHS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.41B | $103.51B | -$93.10B | HCA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UHS REV | HCA REV | UHS GROSS % | HCA GROSS % | UHS FCF | HCA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.36B | $75.60B | — | — | $849.2M | $7.69B |
| FY 2024 | $15.83B | $70.60B | — | — | $1.12B | $5.64B |
| FY 2023 | $14.28B | $64.97B | — | — | $625.1M | $6.51B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UHS // BETA 1.04
HCA // BETA 1.04